中国的机器人外科学杂志 | ISSN 2096-7721 | CN 10-1650/R

中央型肺癌新辅助免疫联合化疗后行机器人袖式重建术一例

Robotic sleeve lobectomy for central lung cancer after neoadjuvant immunochemotherapy

作者:陈求名,汪路明,何哲浩,王志田,曾理平,胡 坚

Vol. 2 No. 1 Feb. 2021 DOI: 10.12180/j.issn.2096-7721.2021.01.004 发布日期:2022-08-06
关键词:中央型肺癌;机器人手术;袖式重建术;新辅助免疫联合化疗

作者简介:

随若科技的进步,肿瘤免疫治疗取得前所未有的成就,部分尤法手术或难以手术的中央型肺癌患者在免疫治疗后重现手术的机会。而机器人手术系统可为肺癌患者带来更微创的治疗方案,通过机器人辅助完成袖式    重建术可最大程度地保证完整切除肿瘤、缩小切除范围和保留健康肺组织。本文介绍一例中央型肺癌患者接受免疫    联合化疗后行机器人辅助袖式重建术,术后恢复顺利,术后 9d 出院,随访 1 年,ECOG 评分为 1 级。

With the advancement of science and technology, tumor immunotherapy has made unprecedented achievements. Some of patients with central lung cancer who is inoperable or difficult to take operation has a chance to take radical resection after neoadjuvant immunotherapy now. The robot-assisted surgery system brings lung cancer patients a more minimally invasive approach, which can make tumor resection more complete, reduce the resection area and maximally preserve

稿件信息

收 稿 日 期 :2020-08-31 录 用 日 期 :2020-11-17 Received Date: 2020-08-31 Accepted Date: 2020-11-17

基金项目:国家重点研发计划(2017YFC0113500,2017YFC0114102),浙江省重大科技专项计划项目(2014C03032),浙江 省中医药(中西医结合)重点学科(2017-XK-A33)

Foundation Item: National Key R&D Program of China (2017YFC0113500, 2017YFC0114102); Major Science and Technology Projects of Zhejiang Province (2014C03032); Key Discipline of Traditional Chinese Medicine in Zhejiang Province (Integrated traditional Chinese and Western Medicine) (2017-XK-A33)

通讯作者:胡坚,Email: dr_hujian@zju.edu.cn

Corresponding Author: HU Jian, Email: dr_hujian@zju.edu.cn

引用格式:陈求名,汪路明,何哲浩,等 . 中央型肺癌新辅助免疫联合化疗后行机器人袖式重建术—例 [J]. 机器人外科学杂志, 2021, 2(1):23-27.

Citation:  CHEN O M, WANG L M, HE Z H, et al. Robotic sleeve lobectomy for central lung cancer after neoadjuvant immunochemotherapy [J]. Chinese Journal of Robotic Surgery, 2021, 2(1): 23-27.

参考文献

[1]Ferguson M K, Lehman A G. Sleeve lobectomy or pneumonectomy: optimal management strategy using decision analysis techniques[J]. Ann Thorac Surg, 2003, 76(6):1782-1788.

[2]Forde P M, Chaft J E, Smith K N, et al. Neoadjuvant PD-1 Blockade in Resectable Lung Cancer[J]. N Engl J Med, 2018, 378(21):1976-1986.

[3]LIANG H, LIANG W, ZHAO L, et al. Robotic Versus Video-assisted Lobectomy/ Segmentectomy for Lung Cancer: A Meta-analysis[J]. Ann Surg, 2018, 268(2):254-259.

[4]Santambrogio L, Cioffi U, De Simone M, et al. Video- assisted sleeve lobectomy for mucoepidermoid carcinoma of the left lower lobar bronchus: a case report[J]. Chest, 2002, 121(2):635-636.

[5]Schmid T, Augustin F, Kainz G, et al. Hybrid video- assisted thoracic surgery-robotic minimally invasive right upper lobe sleeve lobectomy[J]. Ann Thorac Surg, 2011, 91(6):1961-1965.

[6]JIAO W, ZHAO Y, QIU T, et al. Robotic Bronchial Sleeve Lobectomy for Central Lung Tumors: Technique and Outcome[J]. Ann Thorac Surg, 2019, 108(1):211- 218.

[7]Steven A, Fisher S A, Robinson B W. Immunotherapy for lung cancer. Respirology, 2016, 21(5):821-833.

[8]Rocco D, Della Gravara L, Battiloro C, et al. The role of combination chemo-immunotherapy in advanced non- small cell lung cancer[J]. Expert Rev Anticancer Ther, 2019, 19(7):561-568.

[9]PAN X, CHEN Y, SHI J, et al. Robotic Assisted Extended Sleeve Lobectomy After Neoadjuvant Chemotherapy[J]. Ann Thorac Surg, 2015, 100(6):e129-e131.

印象笔记
有道云笔记
微博
QQ空间
微信
二维码
意见反馈